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This study compares the ability of two ultraviolet 
(UV) B-absorbing sunscreens, 2-ethylhexyl p-me-
thoxycinnamate (2-EHMC) and 2-ethylhexyl p-ami-
nobenzoate (Padimate 0), and two physical sun-
sc.;eens, microfine titanium dioxide (MTD) and zinc 
oxide, to protect the skin immune system from 
chronic (4 weeks) solar-simulated UV irradiation. 
Mice were exposed to suberythemal doses of UV 
be£ore assessing local and systemic immunosuppres-
sion and tolerance to a contact sensitizer. Using a UV 
protocol that induced local but not systemic immu-
nosuppression or tolerance in BALB/c mice, it was 
shown that Padimate 0 made the immunosuppres-
sion worse, whereas 2-EHMC and MTD protected the 
immune system. When the cumulative dose was in-
creased by 12.7%, causing systemic immunosuppres-
sion and tolerance, none of the sunscreens protected 
from immunosuppression, but 2-EHMC provided 
E x posure of humans to solar radiation has been closely linked with the development of skin cancer. The biologic effects of the ultraviolet (UV) components of sunlight that could be involved in carcinogenesis include genetic damage, immunosuppression, and 
epid ermal hyperplasia (for review, see [1]) . There is increasing 
evidence thai: UV -induced immunomodulatory e ffects may be 
important in the development of skin cancer in humans [2) . This 
immunosuppression can be detected by impaired generation of 
contact hypersensitivity (CHS) reactions to haptens in both humans 
[2] and laboratory rodents [3) and decreased reactivity against 
highly antigenic tumors in mice [4). 
UV-induced immunosuppression of the CHS response can be 
divid ed into local and systemic effects. A reduced CHS response 
results from the application of a hapten locally to the irradiated site 
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partial, and MTD gave complete protection from 
tolerance. To examine this apparent lack of protec-
tion from systemic immunosuppression, C3H/HeJ 
mice were used. These mice had a minimal erythema 
dose similar to that of the BALB/c mice but were 
systemically immunosuppressed, with only 44% of the 
UV dose required to immunosuppress BALB/c mice. 
2-EHMC provided some protection, whereas MTD 
provided complete protection from systemic immu-
nosuppression in C3H/HeJ mice. Hence, sunscreens 
can protect from local and systemic immunosuppres-
sion, although this protection is limited and is not 
related to the sun protection factor of the sunscreens 
or the minimal erythema dose of the mouse strain. 
Instead, protection seems to be related to the sun-
screens' having a broad absorption spectrum. Key 
tvords: sJmlightlitntrumitylsuppressioulmice. J Iuvest Derma-
to( 105:345-351, 1995 
(local immunosuppression) or to a skin site distal to the irradiation 
site [3,5). Local immunosuppression has been attributed to deple-
tion and functional inactivation of Langerha.ns cells [3,6). The 
production of soluble factors such as cis-urocanic acid, prostaglan-
dins, and keratinocyte-derived factors has been implicated in both 
local and systemic immunosuppression [6-9). On the molecular 
level, DNA damage in the fonn of pyrimidine dimers has been 
implica ted as th e initiating event for both immunosuppressive 
effects of UV [10,11). UV radiation can also induce specific 
tolerance when the same hapten is applied to an unirradiated site at 
a later date [3,12). Tolerance is observed in skin depleted of 
Langerha.ns cells [13) and can be caused by transferable cells with 
suppressor activity. 
T he capacity ofUV radiation to in1pair the CHS response in mice 
has been shown to be genetically detemuned [14). Humans have 
also been demonstra ted to be genetically polymorphic wi.th regard 
to the capacity of UV radiation to impair the induction of CHS to 
a hapten [2). 
Sunscreens protect from many of the UV-induced fonns of 
epidermal damage such as erythema [15), premature skin aging 
[1 6), and skin cancer [17-19), although their effectiveness in 
protecting against UV -induced effects on the iinmune system is 
inconclusive . In a number of human studies, sunscreens h ave been 
shown to protect from genetic dam age [20) but failed to protect.tlui 
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immune system from the effects ofUV radiation (21,22]. In animal 
studies, sunscreens have been shown not to protect against local or 
systemic immunosuppression [23 ,24], although Wolf et al [25] have 
demonstrated a dose-dependent photoprotective ~apacity of sun-
screens from UV-induced local inununosuppression. However, 
most studies on sunscreen protection of the skin immune system 
have adopted large single (25,26] or short-term (27] UV13 irradia-
tion protocols. In this study, we used chronic, low-dose solar-
stimulated UV irradiation, which was designed to simulate closely 
the daily exposure of humans to sunlight, to test whether various 
sunscreens will protect genetically different mice (C3H/HeJ and 
BALB/c) from UV-induced local and systemic immunosuppression 
and tolerance. Furthermore, we compared the capacity of UV13-
absorbing and physical sunscreens (which have a broader absorp-
tion spectrum) to protect the immune system of these mice from 
UV -induced immunosuppression. 
MATERIALS AND METHODS 
Animals Inbred female BALB/c mice were obtained from the University 
of Sydney. Inbred female C3H/I-IeJ mke were obtained from the N ational 
Institute of O ccupational Health and Safety, Camperdown , Sydney, Aus-
tralia. The mice were housed at Royal Prince Alfred Hospital Animal House 
and fed standard laboratory mouse pellets and water ad libi111111 . Lighting was 
controlled using a 12-h light and 12-h dark cycle. Animals were 10-12 
weeks old at the beginning of experiments. 
UV Irradiation Simulated solar UV radiation was provided by a bank of 
six Cosmolux R.A plus A l-14-lOOW UV A tubes Aanking a single FS72T12-
UVB-HO tube. Emitted radiation was filtered through a layer of cellulose 
triacetate film (0.5 mm; Eastman Kodak, Rochester, NY) to filter out 
wavelengths below 290 nm (UVC). T he integrated irradiancc was 1. 7 X 
10- 4 W /cm2 for UVB (290-320 nm) and 3.4 X 10- 3 W /cm2 for UV A 
(320-400 nm), as measured by an IL1 350 radiometer and using an SED 038 
(UVA) or an SED 240 (UVB) detector. The emission spectra were 
measured at the Commonwealth Scientific and lndustrial Research Organi-
sation (Australia) . 
Mice were shaved with a Remington Microscreen shaver and irradiated 
while unrestricted in their cages. Sunscreens were applied dorsally to the 
irradiation site at least 10 min before each irradiation at approximate ly 2 
mg/cm2 • In all experiments, the starting dose of UV for the C3H/HeJ 
mouse strain was 14 min, whereas for the BALB/c mouse strain it was 30 
min. Mice were irradiated 5 d per week for 4 weeks. To overcome acquired 
tolerance, the exposure time was increased each week by either 20% 
("protocol 1" UV treatment groups) or 30% ("protocol 2" UV treatment 
groups) . The average cumulative dose for the BALB/c mouse strain using 
protocoll was 7.1 j/cm2 for UVB and 141.0 Jlcm2 for UVA. Using the 
higher protocol 2 UV irradiation treatment, the BALB/c groups received an 
average cumulative dose of 8.0 j /cm2 UVB and 158.4 Jlcm2 UVA, a total 
increase of 12.7% in the average cumulative dose . The C3H/HeJ mice 
received 3.5 j /cm 2 UVB and 68.2 j/cm2 UVA using UV irradiation 
protocol 2. 
Sunscreens Sunscreens were prepared in an oil-in-water emulsion (base 
lotion). They contained either 8% 2-ethylhexyl p-aminobenzoate (Padimate 
0), 8% 2-ethylhe,.:yl p-methoxycinnamate (2-EHMC), or 7.2% microfine 
titanium dioxide (MTD). For the study on the effects of adding oxygen 
radical scavengers to the sunscreens, 0.1% butylatcd hydro>:ytoluene and 
0.5% a-tocopherol were added to the above formulations. A commercial 
zinc oxide cream b.p. was used in selected experiments. 
Determination of Sun Protection Factor (SPF) of Sunscreens Ill 
Vivo By permission of the Australian Photobiology Testing Facility, we 
used a Model 12S solar simulator (Solar Light Co., Philadelphia, PA) 
con taining a 150-W xenon lamp with a dichroic mirror and 1-mm UG 11 
and 1-mm WG320 filters (Schott Glass Tech. Inc., Mainz, Germany) to cut 
off all UV radiation below 290 nm. The system has been described 
previously [28]. The emission spectra were measured at the Commonwealth 
Scientific and Industrial Research Organisation (Australia) using a McPher-
son triple grating monochrometer. The incident integrated irradiance was 
2 .15 WI cm2 tota l UV. The xenon lamp was used to determine the SPF of 
the sunscreens, as the spectra for the Auoresccnt and xenon light sources arc 
sin1ilar (Fig 1), but the xenon source emits approximately 60-fold higher-
intensity UV irradiation over a small diameter compared with the Auorcs-
cent solar sim ulator, thus making it possible to determine the SPF of the 
sunscreens within reasonable time frames . 
The inAammatory response was used to determine the SPF of the 
sunscreens. The shaved backs of the animals were exposed to a 0.8-cm 2 
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Figure 1. The relative spectral irradiance of the xenon and fluo-
rescent solar simulators approximates the solar spectrum below 
370 nm. Solar spectrum was measured at noon on January 17, 1990 at 
Melbourne (38°S). (Reproduced by permission from Gies et nl [39].) 
circular area at the focal point of the source. Skin swelling was determined 
as the change in double skinfold thickness before and 24 and 48 h after 
irradiation, as measured by an engineer's micrometer (Mercer, St. Albans, 
England) . The dose of solar-simulated UV radiation that caused a minimal 
inAammatory response was detennined in both BALB/c and C3H/HeJ 
mouse strains. To determine the SPFs, we appl.ied 2-EHMC, Padimate 0 , 
MTD, zinc oxide cream, and base lotion to groups of four BALB/c mice 
and exposed the anin1als to increasing multiples of the UV dose that caused 
a minimal inAammatory response, i.e ., the minimal inflammatory dose 
(MID). T he SPF was ca lculated as the ratio of the highest UV dose at which 
a sunscreen protects from inflammation compared with unprotected skin. 
Determination of the Relative Spectral Transmission of the Sun-
screens Ill Vitro An Optometries SPF Spectrophotometric System was 
used to measure the transmission of UV l.ight using a tape substrate 
(Transpore Tape; 3M, Sydney, Australia), which has surface irregularities 
similar to human skin. Transmission of UV radiation through the substrate, 
w ith and without sunscreen applied, was determined automatically by 
recording photocurrent in 5-nm steps from 290 to 400 nm. Spectroradio-
metric measurement of the transmission of UV radiation through the 
substrate also allowed prediction of the SPF values for each sunscreen 
according to the following formula, as described by Dilfey and Robson [29]: 
SPF = LiggE(A)e(A)/L188E(A)e(A)/PF(A), 
where E(A) is the spectral irradiance of terrestrial sunlight under defined 
conditions, e(A) is the relative effectiveness of UV radiation at each 
wavelength (A nm) in producing delayed erythema in human skin (the 
erythema action spectrum), and PF(A) is the monochromatic protection 
factor at wavelength (A nm) and is the reciprocal of the mean transmittance 
at any given wavelength. 
The relative spectral transmissions of the sunscreens and base lotion were 
determined by applying the lotions to the substrate such that the SPF 
calculated by the Optometries System was the same as the SPF determined 
iu 11i11o. 
Contact Sensitization T he primary CHS response resulted from the 
app lication of a hapten either locally to the irradiated site (local immuno-
suppression) or to a skin site distal to the irradiation site (systemic 
immunosuppression). The secondary CHS response resulted from a second 
attempt at sensitizati.on; mice th11t remained unresponsive (f:~iled to develop 
a secondary CHS response) were regarded as tolerant. 
For contact sensitization experiments, the ears of the mice were shielded 
from UV irradiation using black electrical tape while they were UV-
irradiated on their dorsal trunks . For loca l immunosuppression, the mice 
were sensitized loca ll y on the irradiated site 3 d after the final irradiation 
(day 0). The C3H/HeJ mice were sensitized with l 00 J,LI of 2% 2,4,6-
t:rin.itroch.lorobenzene (TNCB) (Tokyo Kasei, J apan) in acetone/olive oil 
(4 :1, v/v) on day 0 and day 1. Sim.ilarly, the BALB/c mice were sensitized 
with 100 J.LI of 7%, TNCB in the same solvent. T hese TNCB doses gave 
maximal CHS responses in the respective mouse strains. For systemic 
immunosuppression, mice were UV-irradiated on their dorsal tnmks but 
were sensitized with TNCB at an m~irradiated site 3 d after the last 
irradiation. 
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Regardless of sensitization site, to assess the CHS response, mice were 
challenged on day 7 with 5 fLl of 1% TNCB on each side of the right ear. 
The left ear was not challenged. Ear swcUing was assessed 24 h later using 
an engineer's micrometer. The CHS response was calculated as the 
difference in tluckness between the right and left car minus the nonspecific 
irritant response for that mouse strain. The CHS response detennincd by 
thjs first sensitization witl1 the contact sensitizer was the primary CHS 
response. 
Four weeks after the initial sensitization (day 28), mice were resensitized 
with the re levant TNCB concentration (depending on mouse straill) at a site 
distal to the initial sensitization site (i .e., the abdomen for mice i1utiaiiy 
sensitized on tl1e dorsal trunk; the dorsal trunk for nuce initially sensitized 
on the abdomen). The right ear of each mouse was challenged 7 d later, and 
the secondary CHS response was determined by measuring ear swelling. 
Histology Skin samples were obtained from UV-irradiated (protocol 2) 
and sunscreen-treated mouse groups, and tl1e relevant controls. for hema-
toxylin and eosi.n stai1ung. Dorsal skin was removed from two mice per 
treatment group 3 d after the last treatment (at tl1e time of contact 
sensitization) and snap frozen in liquid nitrogen before cryostat sectioning 
and staining. Histology was assessed on six randomly chosen areas from 
each treatment group. Epidem1al hyperplasia was assessed by measuring the 
thickness of the epidem1 is using a microscope micrometer. Kerati1uzation 
and dermal hyperplasia were rated using a visual scoring system. 
Analysis of Data T he immunoprotective capacity of the sunscreens was 
assessed by comparison with the UV -irradiated, base-lotion-treated group 
and the unirradiated, shaved-only group. A group whose CHS response was 
significantly lower than that of the unirradiatcd, shaved-only group, but not 
significantly difFerent from the UV-irradiated, base-lotion-treated group, 
was considered not to have been protected. A group whose CHS response 
was not significantly difFerent from the unirradiated, shaved-only group and 
significantly higher than the UV-irradiated, base-lotion- treated group was 
regarded as fully protected. Partial protection was recorded when the CHS 
response of a group was between tl10se of the UV plus base and the 
shaved-only groups and either significantly diJfcrent from both or not 
significantly difFerent from either. 
Results arc presented as the mean ± SEM for each mouse group. Each 
treatment group consisted of six to seven mice. The one-way analysis of 
variance (ANOVA) for factorial models was used to ana lyze data, unless 
otherwise stated. Because of the large number of groups that were 
compared with each other, p < 0.01 was regarded as significant. 
RESULTS 
Emission Spectra of the Solar Simulators The emission 
spectra of the fluorescent and xenon light sources were measured, 
and their relative spectral irradiances are shown in Fig 1. The 
fluorescent and xenon solar UV simulators displayed similar spec-
tral irradiances, although the fluorescent solar UV siJnulator emit-
ted slightly more of the short UVB wavelengths (280-300 nm) and 
slightly less of the long UVB and short UVA wavelengths (300-340 
nm). When compared with the spectrum of sunlight, the solar 
simulators contained slightly more UVB in the 280-300-nm range 
of t he spectrum, but slightly less UVB in the 300-320-nm range of 
the spectrum. Unlike the solar UV simula tors, however, sunlight 
emi tted high levels of the long UV A wavelengths (370 - 400 nm) 
and continued to emit beyond the UV A spectrum. 
SPF of Sunscreens The SPF of each sunscreen was determined 
in vi11o using BALBI c mice and a xenon arc solar UV simulator. The 
UV- irradiation dose that gave a minimal inflammatory response in 
BALB/c mice using the xenon arc source was 0.3 J lcm 2 • Similarly, 
using the fluorescent source, the MID was 0.35 j/cm2 . The MID in 
C3H/HeJ mice was 0.3 Jlcm 2 using the fluorescent source. Groups 
ofBALB/c mice were irradiated at increasing multiples of the MID, 
and the SPFs of the sunscreens were as follows: 2-EHMC = 4; 
Padimate 0 = 4; MTD = 7; zinc oxide = 9; base lotion = 1. 
Relative Spectral Transmission of Sunscreens The trans-
mission spectra were determined by the Optometries System for 
each sunscreen at the SPF each sunscreen provided i11 JJiJJo. Tlus 
gave an accurate representation of the UV radiation spectra trans-
mitted by each sunscreen to the skin of the mice . Both Padimate 0 
and 2-EHMC sunscreens disp layed considerable absorption in the 
UVB range of the spectrum (290-320 nm) (Fig 2). T here was a 
rapid decrease in absorption after 320 nm for Padimate 0 and after 
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Figure 2. Different relative spectral transmissions of the sun-
screens were observed at the SPF determined i11 vit>o. 
330 nm for 2-EHMC, with 2-EHMC absorption being sligh tly 
greater in the lower UV A range (320-340 mn) . The MTD and zinc 
oxide cream sunscreens displayed a broad-spectrum absorption 
pattern (290-400 nm), with a considerable increase in absorption 
in the UV A range compared with Padimate 0 and 2-EHMC 
sunscreens (Fig 2). 
Sunscreens Affect UV-Induced Immunosuppression in 
BALB/c Mice BALB/c mice were treated with or without 
sunscreen or base lotion and UV-irradiated 5 d per week for 4 
weeks with a starting dose of 0.8 MID. This dose was previously 
determined to reduce the CHS response to TNCB. 
In the absence of UV irradiation, the sunscreens and base lotion 
did not cause any statistically significant changes in prin1ary or 
secondary responses compared with the shaved-only treated group 
(results not presented). 
The CHS responses of BALB/c mice treated with or without 
sunscreen or base lotion and UV-irradiated using protocol 1 are 
shown in Fig 3a. The primary CHS response of UV - only treated 
mice that were sensitized locally was significantly lower than that of 
the shaved, unirradiated group (ANOVA, p < 0.01). Irradiated 
mice that were sensitized systemically (UV systemic) were not 
significantly different from the shaved group. Thus, this protocol 
caused loca.l but not systemic immunosuppression. Animals UV-
irradiated with base lotion were not significantly different from the 
shaved-only group or from the UV -only group (ANOV A) and 
therefore were partially protected . Padimate 0 did not protect from 
UV-induced immunosuppression. 2-EHMC and MTD completely 
protected from UV -induced immunosuppression, as these groups 
were significantly lugher than the UV plus base treated group and 
were not sig~uficantly different from tl1e unirradiated, shaved-only 
group. After a second sensitization, there was no reduced secondary 
response observed in any of these groups (Fig 3a). 
When the average cumulative dose of UV was increased by 
12.7% (protocol 2), the untreated irradiated groups were both 
locally and systenucally immunosuppressed compared with the 
unirradiated, shaved controls (ANOVA, p < 0.01) (Fig 3b). The 
base lotion provided no protection . Non e of the sunscreens pro-
tected these mice from UV-induced primary immunosuppression, 
as none of these groups were significantly different from the UV 
plus base group (Fig 3b), and all were significantly lower tl1an the 
shaved-only group. After the second sensitization, botl1 untreated 
UV-irradiated groups and the base-lotion-treated group remained 
immunosuppressed and were therefore regarded as tolerant (Fig 
3b). Padin1ate 0 did not protect from tolerance. 2-EHMC partially 
protected from tolerance, as this group was not significantly 
different from either the shaved-only or tl1e UV plus base treated 
groups. MTD completely protected the mice from tolerance and 
therefore was the best sunscreen in this mouse strain. 
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Figure 3. MTD and 2-EHMC protect the primary CHS response of 
BALB/c mice from protocol 1 UV irradiation (a) but not from the 
higher UV dose of protocol 2 (b). Mice were treated with one of the 
sunscreens Padimate 0 (Pad 0), 2-EHMC, MTD, or base lotion 5 d per 
week for 4 weeks. For CHS,TNCB was applied locally at the site of 
irradiation on all mice except for the "UV (systemic)" group (where it was 
applied distal to the site of irradiation). Data are mean ::':: SEM; n = 6. *p < 
0.01 versus shaved-only group; •p < 0.01 versus UV plus base (ANOVA). 
Sunscreens Affect the CHS Response in C3H/HeJ Mice 
Unirradiated mice were sensitized on sunscreen-treated skin, and 
the primary CHS responses are shown in Fig 4a. The group treated 
with base lotion was not signifi cantly different from the untreated 
group. All sunscreens, however, significantly reduced the CHS 
response compared with the shaved- only, untreated group 
(ANOVA, p < 0.01). The reduced CBS response in these unirra-
diated mouse groups meant that any UV-i.rradiation experiments 
would be uninterpretable. We overcame the im.munosuppressive 
effects of the sunscreens in the absence of UV radiation in 
C3H/HeJ mice by adding the oxygen radical scavengers butylated 
hydroxytoluene and a-tocopherol to Padimate 0, 2-EHMC, and 
MTD stmscreens and to the base lotion. The CHS response of mice 
treated with these sunscreens in the absence of UV radiation is 
shown in Fig 4b. Neither the sunscreens with oxygen radical 
scavengers nor the base lotion or zinc oxide cream had any 
significant effect on the CHS response compared with the shaved-
only controls. 
The C3H/HeJ mice were irradiated 5 d per week for 4 weeks 
with a starting dose of0.4 MID, predetermined to cause both local 
and systemic immunosuppression as well as tolerance . The primary 
CHS response of the UV-only treated mice that were sensitized 
locally was significantly lower than that of the w1.irradiated, shaved 
controls (Fig 5). The base lotion did not protect against this 
immunosuppression. Padimate 0 did not protect tlus mouse strain 
from UV -induced immunosuppression, as this group was not 
significantly different from the UV -irradi ll ted, base-lotion-treated 
group (ANOVA). The 2-EHMC sunscreen partially protected from 
UV-induced immunosuppression, as tlus group was significantly 
higher than the UV plus base treated group but remained signifi-
cantly lower than the unirradiated, shaved group (Fig 5). The 
MTD and zinc oxide sunscreens proved to be completely protec-
tive against UV -induced immunosuppression. 
After the second sensitization, the secondary response in the 
UV-only group was significantly lower than that of the shaved-only 
group and was therefore regarded as tolerant (Fig 5) . The base 
lotion did not protect from tolerance. Padimate 0 also did not 
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Figure 4. Oxygen radical scavengers inhibit sunscreens from im-
munosuppressing C3H/HeJ mice in the absence ofUV radiation. a) 
Mice were treated with one of the sunscreens Padimate 0 (Pad 0), 
2-EHMC, MTD, or base lotion 5 d per week for 4 weeks. A control group 
of mice was shaved but not treated with any lotion. b) a-tocopherol and 
butylated hydroxytoluenc were added to Pad 0, 2-EHMC, MTD , and the 
base lotion. Zinc oxide cream did not contain the m.:ygen radical scaven-
gers. For CHS, TNCB was applied locally on all mice. Data are mean ::':: 
SEM; n = 6. *p < 0.01 versus shaved-only group (ANOVA). 
protect from tolerance, as it was not significantly different from the 
UV plus base treated group. The 2-EHMC sunscreen partially 
protected from tolerance, as it was not significantly different from 
either the UV plus base or the shaved-only treated groups. MTD 
and zinc o:bde sunscreens completely protected from tolerance. 
UV Irradiation Effects on Histology Arc Altered by Sun-
screens Histologic assessment of BALBI c and C3H/HeJ mouse 
skin was done on hematoxylin and eosin- stained frozen sections of 
skin taken from irradiated and sunscreen-treated mice. Results for 
the two mouse strains were similar, and hence only the BALB/c 
data are summarized in Table I. In the unirradiated treated groups, 
there were no increases in epidermal tluckening with any of the 
sunscreens or base-lotion treatments when compared with the 
CONTACT HYPERSENSITIVITY 
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Figure 5. Zinc oxide and MTD completely protect, and 2-EHMC 
partially protects, C3H/HeJ mice from UV irradiation (protocol 2). 
The mice were treated with one of the sunscreens Padimate 0 (Pad 0), 
2-EHMC, MTD, or base lotion containing ox-ygen radica l scavengers 5 d 
per week for 4 weeks. Zinc oxide cream did not contain 01>.-ygen radical 
scavengers. All groups were sensitized locally with TNCB at the site ofUV 
iuadiation. Data are mean ::':: SEM; n = 6. *p < 0.01 versus shaved-only 
group; •p < 0.01 versus UV plus base (ANOVA) . 
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Table I. Padimate 0 and 2-EHMC, But Not MTD, Cause 
Histologic Changes in UV-Irradiated BALB/c Mice 
EpidennaJ Dermal 
Treatment Thickness (Jl.m)" Keratinization1' Thickeningb 
Shave only 1.69 :':: 0.13 
Base lotion 2.06 :':: 0.72 + 
Padimate 0 3.15 :':: 0.87 ++ ++ 
2-EHMC 1.92 :':: 0.14 + 
MTD 2.25 :':: 0.35 + 
UV only 1.81 :':: 0.63 ++ 
UV + base lotion 2.38 :':: 0.32 + + 
UV + Padimate 0 5.15 :':: 0.45' ++ ++ 
UV + 2-EHMC 3.90 :':: 0.88' + ++ 
UV + MTD 2.38 :':: 0.53 + 
" Epiderma l thickness was expressed as mean ± SD. 
b A visual scoring system was used to determine keratinization and dcnna_l thicken-
ing. such that a large increase was scored as ( + + ) and a small change was scored as 
(+). 
c Mean of the treated brroup minus twice the SO of that group was greater than the 
mean of the sb;tvcd-on_ly group plus twice the SD and was therefore regarded as 
different from the shaved-only group. 
untreated, shaved group. Padimate 0, however, increased kerati-
nization and dermal thickening (Table 1). 
Our chronic VV-irradiation protocol did not increase epidennal 
thickness but increased keratinization compared with the unirradi-
ated control group (Table 1). Increased epidermal and dermal 
thickness was observed in the UV-irradiated Padin1ate 0 and 
2-EHMC-treated groups, while Padinlate 0 also increased kerati-
nization. There were no significant changes observed in MTD-
treated, VV-irradiated mice. No in£lammatory cells were observed 
in any of the samples. 
DISCUSSION 
We studied sunscreen protection from solar-simulated VV irradi-
ation using 4 weeks of daily low-dose UV exposure in two mouse 
strains of differing sensitivities to UV-induced immunosuppression 
but sin1ilar sensitivities to UV-i.nduced erythema . Different VV 
protocols were used, which caused local and systemic immunosup-
pression. This system was designed to sim ulate daily nonerythe-
matic exposure to sunlight by humans. The results were correlated 
with the SPF and transmission spectra of the sunscreens as well as 
with histologic changes in the skin. This enabled us to examine 
systematically the factors that influence sunscreen protection from 
VV -induced immunosuppression. 
Chronic exposure of our mice to solar-simulated UV radiation 
decreased the CHS response to the hapten TNCB. UV irradiation 
of the BALBI c mice over 4 weeks using the higher protocol 2 VV 
irradiation caused systemic immm1osuppression and tolerance. 
However, we found that if the cumulative UV dose was decreased 
by 12. 7%, there was local, but not systemic, immunosuppression or 
tolerance . T lus is in agreement with other studies, which have 
shown that there may be different mechanisms involved in initiating 
local and systemic immunosuppression and that the UV dose-
responses for local and systemic immunosuppression differ [14, 
30,3 1]. h1 addition, the dose ofVV radiation that caused local but 
not systemic immunosuppression did not induce tolerance; there-
fore, systemic immunosuppression may be necessary for long-term 
tolerance. This has also been observed by K urimoto and Streilein 
[32]. 
In these experiments, the two mouse strains responded to sin'til ar 
MIDs-0.35 j/cm2 for the BALB/c mouse strain and 0.3 j/cm2 for 
the C3H/HeJ mice-although they differed in their susceptibility to 
VV -induced immunosuppression. Using our UV -irradiation proto-
col, the starting UV-irradiation dose we found necessary to immu-
nosuppress the BALB/c mice was 0.8 of the MID, whereas only 0.4 
MID was required to suppress C3H/Hej mice . Preliminary data 
determined that decreasing by half the dose of VV delivered to the 
BALB/c nuce did not immunosuppress these mice locally or 
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systemically (data not shown). Protocol! was therefore regarded as 
the minimal in1munosuppressive dose for BALB/c mice. H e nce, 
using our UV-irradiation protocol, the C3H/HeJ mice were more 
susceptible to UV-induced immunosuppression than were the 
BALB/c mice, even though they both had a similar MID. Other 
groups have also demonstrated that different mechanisms are 
involved in UV-induced immunosuppression and UV-induced 
inflammation [22,23,25,33]. 
In BALB/c mice, we have demonstrated VV-irradiation proto-
cols that ca used e ither local or systemic immunosuppression (pro-
tocols 1 311d 2, respectively). In both protocols, BALB/c mice were 
VV-irradiated with a starting dose of only 0 .8 MID, and this was 
increased weekly by 20% and 30% for protocols 1 and 2, respec-
tively. The base lotion, which had 311 SPF of 1, partially protected 
the CHS response from protocol 1 . The reasons for tlus a.re 
unknown. Padimate 0 provided no protection and therefore made 
the immtmosuppression worse than the base lotion. Tlus was 
observed even though Padimate 0 has an SPF of 4 and therefore 
trans nuts only one quarter the amount of UVJ3 compared with the 
base lotion. MTD and 2-EHMC gave complete protection from 
UV-induced local immunosuppression. 
When tl1e cmnulative UV dose was increased by 12. 7%, systenuc 
inununosuppression and tolerance were observed. The base lotion 
no longer protected from UV-induced immw10suppression or 
toler31Ke. None of the sunscreens protected the BALB/c mice from 
tlus VV protocol. Resensitization of the sunscreen- treated groups 
showed that Padimate 0 did not protect from tolerance and 
therefore was the least protective sunscreen i.n tlus mouse strain. 
2-EHMC partially protected from tolerance. The inability of 
2-EHMC to protect from systemic immunosuppression compared 
with its protection from local immunosuppression could not have 
bee n predicted from its SPF; 2-EHMC was shown to have an SPF 
of 4, and therefore we would expect it to protect from a fourfold 
increase in the UV dose. However, it did not protect from 311 
increase of only 12.7% in the UV dose compared with the nu.tumal 
immunosuppressive dose in protocol 1. Hence, the immunologic 
protection factor of 2-EHMC was between 1 and 1.127. To 
determine tlus, we have defined the immunologic protection factor 
as the ratio of the highes t UV dose at wluch tl1e sunscreen will 
protect from UV-induced immunosuppression compared with the 
minimal immunosuppressive dose . In addition, the differential 
protection provided by Padimatc 0 and 2-EHMC could not be 
explained on the basis of their SPFs, as both sw1screens had 311 SPF 
of 4. Differences in immunoprotection between the two UVJ3-
absorbing sunscreens may, however, be due to their different 
absorption spectra; 2-EHMC has a s.lightly broader absorption 
spectrum than Padimate 0. 
It was surprising that a 12.7% increase in the UV dose compro-
mised the immunoprotective capacity of MTD such that it did not 
protect from systemic immunosuppression, considering that it had 
an SPF of7, mu ch greater than that of2-EHMC 311d Padimate 0. 
Therefore, MTD, like 2-EHMC, had an immunologic protection 
f.1ctor of less than 1.127. However, MTD did protect from 
tolerance and therefore provided better immunologic protection 
than Padimate 0 or 2-EHMC. This is likely to be due to its 
broad-spectrm11 UV protection compared with Padimate 0 and 
2-EHMC. Hence, the immunoprotective capacities of the sun-
screens are very low and are not related to the SPF of the 
sunscreens; tlus may be due to different action spectra for erythema 
and immunosuppression. It was also demonstra ted that sunscreens 
with a broader spectral absorbency have a lugher immunoprotec-
tive capacity. Furthermore, the ability of MTD to protect from 
tolerance and not from systemic immm10suppression suggests that 
there may be different m ech31usms involved in UV-induced sys-
temic immunosuppression and tolerance. To our knowledge, tlus 
has not been demonstrated previously. 
Other studies have also shown poor immtmoprotective capacity 
by Padimate 0 [15,23,33] and conflicting evidence on the immu-
noprotective capacity of 2-EHMC [24,25,33 ,34]. Greenoak et a/ 
[19] have shown MTD to be protective against tumor formation in 
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mice, and Diffey and Farr [3 5] have dem o nstrated increased 
photoprotection in humans by sunscreens containing MTD com-
pared with UVB absorbers. T o our knowledge, however, there 
h ave been no previous studies on protection of the CHS respon se 
by MTD from chronic solar-simulated UV radiation. 
To determine whether sunscreen protection in BALB/c mice 
from protoco l 1 but not protocol 2 UV irradiation could be due to 
protection from local but not sys temi c immunosuppression, a more 
sen sitive mouse strain was examined. However, all sunscreens 
caused immunosuppression in the C3H/HeJ mouse strain in the 
absence of UV radiation. The base lotion , however, may have 
contributed to the reduced CHS responses seen in the sunscreen-
treated groups even though it did not cause a significant decrease 
on its own. T he mean of the CHS response in the base-lotion-
treated group was reduced, and hence it is possible that there were 
additive immunosuppressive effects of the base lotion to the 
sunscreens, causing a significant decrease in the sunscreen- treated 
groups . Significantly reduced CHS reactions have also been 
observed in unirradiated Sk.h:HR-2 mice treated with various 
commercial sunscreens (V .E. Reeve, personal communication). 
Strickland et nl [36] also reported a reduced, but not statistically 
significant, CHS response in vehicle-treated C3H/HeN mice . 
T here is evidence that p-aminobenzoic acid, and to a lesser extent 
Padimate 0 and 2-EHMC, can cause contact and photocontact 
sensitization in humans and exhibit cross-reactivity with commonly 
used chemicals, fragrances, and preservatives (reviewed in [37,38]). 
T he reduced CHS response observed .in mice treated with MTD, 
however, was unexpected because MTD is particulate and insolu-
ble, and therefore unlikely to penetrate the skin [19]. The immu-
nosuppressive effects of the stmscreens, and possibly the base lotion , 
on their own in the C3H/HeJ mice were overcome by the addition 
of oxygen radical scavengers to the sunscreens, enabling us to use 
these mice. T he m echanism responsible for this is unknown, but it 
indicates that oxygen radical scavengers may be beneficial in 
sunscreens and cosmetics used by humans, as immunosuppression 
in hun1an s using st:1ch preparations for extended periods m ay not be 
easily detected . 
T he C3H/HeJ mice, which had a MID similar to the BALB/c 
mice, were systemically immunosuppressed, with only 44% of the 
cumulative UV dose required to systemically ilnmunosuppress 
BALB/c mice. T hese mice were not protected from UV-induced 
immunosuppression or tolerance by the base lotion or by Padimate 
0, and were only partially protected by 2-EHM C even though the 
mice were irradiated with only 0.4 MID per day. As both Padimate 
0 and 2-EHMC had the same SPF (SPF = 4), the increased 
protection by 2-EHMC compared with Padimate 0 in tlus mouse 
strain did not correlate with SPF. MTD and zinc oxide protected 
the C3H/HeJ mice from both UV-indu ced immunosuppression 
and tolerance and therefore w ere the best sunscreens in tlus mouse 
strain. Compared with Padimate 0, the increased protection by the 
other sunscreens correlates with broader UV absorptions extending 
into the high UVB, low UV A wavelengths. T hese experiments 
show that 2-EHMC and MTD can protect from systemic immuno-
suppression and tolerance; hence the inability to p rotect BALBI c 
nuce from protocol 2 UV irradiation was not due to an inability to 
inlubit the cellular/molecula r mechmusm s responsible for systemic 
immtmosuppression . 
There is som e correlation between the observed effects of UV 
irradiation on the immune system and histologic alterations. Padi-
mate 0 and 2-EHM.C were the least im.munoprotective sunscreens 
in both mouse strains and, furthermore, actually induced epidermal 
and dermal tluckening compared with the untreated group. Padi-
mate 0 continued to induce keratinization, as seen in the unirra-
diated treated group , and was therefore the worst sunscreen. O ur 
observations could be due to the nature of the sunscreen s; they are 
chemical absorbers that penetrate the skin and therefore may 
interact wi th various cutaneous molecules to cause the above 
effects. MTD, however, provides a physica l barrier , is not photo-
reactive or sensitizing [37], and therefore did not cause significant 
epidermal thickening or immunosuppression. 
T H E J O URNA L OF INVESTIGATIVE DERMATOLOGY 
W e have shown, using our solar-simulated UV-irradiation pro-
tocols, tha t sunscreens offer some, but minimal, immunoprotection , 
wluch could not be predicted from the SPF. Our UV-radiation 
protocol was designed to model the daily suberythemic eJ.:posure of 
humans to sunlight. T lus avoided the molecular events associated 
with erythema. The immunoprotective capacity of sunscreens 
correlated m ainly with the absorption spectra of the sunscreens: 
MTD and zinc ol\.'ide effectively absorb and/ or reflect both UV A 
and UVB and were the best sunscreens in C3H/HeJ mice, whereas 
MTD was the best sunscreen in BALB/c mice. N either 2-EHMC 
nor Padimate 0 , wluch absorb UVB but not UV A, completely 
protected from UV -induced immunosuppression in either the 
BALB/c or C3H/HeJ mouse strain. This suggests possible delete-
rious effects by the longer UV wavelengths on the skin immune 
system after chronic solar-simulated UV irradiatio n. 
We 1110111d like to thauk Cavill C reeuoak fi, · lleiJiflll diswssioiiS awl expertise iu solar 
simulatiou. This project zvas supp011ed by tire D enunlology R esenrclr Fouudntiou of 
A ustralia. 
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